8-K: Current report
Published on December 3, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): December 2, 2009
IDEXX
LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-19271
|
01-0393723
|
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
of
incorporation)
|
|
One
IDEXX Drive, Westbrook, Maine
|
04092
|
|
(Address
of principal executive offices)
|
(ZIP
Code)
|
207.556.0300
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. to Form 8-K):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
5.02.
|
Departure
of Directors or Principal Officers; Election of Directors; Appointment
of
|
|
Principal
Officers
|
William
Wallen, 66, will retire from IDEXX Laboratories, Inc. (the “Company”) effective
as of March 3, 2010. Dr. Wallen has been Senior Vice President and
Chief Scientific Officer of the Company since joining the Company in September
2003. Dr. Wallen’s retirement is consistent with a December 2008
agreement with the Company under which he agreed to retire in the first quarter
of 2010 to permit the succession of William Brown, 55, as Chief Scientific
Officer. Dr. Brown
joined the Company in December 2008 as Corporate Vice President, Instrument
Research and Development and Manufacturing. Prior to joining the Company, from
1982 to 2007, Dr. Brown held various positions at Abbott Laboratories, Inc., a
publicly held, global pharmaceuticals, nutritional and medical products company,
most recently as Corporate Officer and Vice President of R&D, Assays and
Instrument Systems for the Diagnostic Division.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
IDEXX
LABORATORIES, INC.
|
||
|
Date:
December 3, 2009
|
By:
|
/s/
Conan R. Deady
|
|
Conan
R. Deady
|
||
|
Corporate
Vice President, General Counsel
|
||
|
and
Secretary
|
||
3